U.S. Markets open in 4 hrs 41 mins
  • S&P Futures

    4,322.00
    +4.25 (+0.10%)
     
  • Dow Futures

    34,021.00
    -22.00 (-0.06%)
     
  • Nasdaq Futures

    14,072.75
    +86.00 (+0.61%)
     
  • Russell 2000 Futures

    1,916.70
    -11.60 (-0.60%)
     
  • Crude Oil

    87.06
    +0.45 (+0.52%)
     
  • Gold

    1,793.10
    -1.90 (-0.11%)
     
  • Silver

    22.57
    -0.11 (-0.49%)
     
  • EUR/USD

    1.1138
    -0.0009 (-0.0780%)
     
  • 10-Yr Bond

    1.8070
    0.0000 (0.00%)
     
  • Vix

    30.32
    -1.64 (-5.13%)
     
  • GBP/USD

    1.3378
    -0.0003 (-0.0241%)
     
  • USD/JPY

    115.6070
    +0.3050 (+0.2645%)
     
  • BTC-USD

    36,526.70
    -11.57 (-0.03%)
     
  • CMC Crypto 200

    828.04
    +8.54 (+1.04%)
     
  • FTSE 100

    7,485.49
    -68.82 (-0.91%)
     
  • Nikkei 225

    26,717.34
    +547.04 (+2.09%)
     

Analysts Have Mixed Reactions On Cintas Q1 Earnings

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • CTAS
  • BofA analyst Gary Bisbee raised Cintas Corp's (NYSE: CTAS) price target to 0 (implying an upside of 4.7%) from 3 and maintained a Neutral rating on the shares after the company reported Q1 results.

  • Bisbee said that organic CC same-days revenue rose a "healthy" 8.6% year-over-year, as it continues to comp the year-over-year declines seen at the start of the pandemic.

  • Bisbee noted that margins rose a little more than expected, which along with a lower tax rate drove a "healthy" EPS beat.

  • Morgan Stanley analyst Toni Kaplan lowered the price target to $365 (implying a downside of 4.5%) from $368 and maintained an Equal-Weight rating on the shares.

  • Price action: CTAS shares are trading lower by 1.53% at $383.32 on the last check Thursday.

Latest Ratings for CTAS

Sep 2021

B of A Securities

Maintains

Neutral

Sep 2021

Morgan Stanley

Maintains

Equal-Weight

Sep 2021

Morgan Stanley

Maintains

Equal-Weight

View More Analyst Ratings for CTAS
View the Latest Analyst Ratings

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.